Skip to main content

Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis

Publication ,  Journal Article
Tan, IB; Tan, P
Published in: Nature Reviews Clinical Oncology
2011

coloprint® is an 18-gene expression signature designed to predict disease relapse in patients with early-stage colorectal cancer (cRc). we discuss the potential impact of coloprint® on clinical practice, and its contribution to our knowledge of cRc molecular heterogeneity. © 2011 Macmillan Publishers Limited. All rights reserved.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nature Reviews Clinical Oncology

DOI

ISSN

1759-4774

Publication Date

2011

Volume

8

Issue

3

Start / End Page

131 / 133

Related Subject Headings

  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tan, I. B., & Tan, P. (2011). Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis. Nature Reviews Clinical Oncology, 8(3), 131–133. https://doi.org/10.1038/nrclinonc.2010.229
Tan, I. B., and P. Tan. “Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis.” Nature Reviews Clinical Oncology 8, no. 3 (2011): 131–33. https://doi.org/10.1038/nrclinonc.2010.229.
Tan IB, Tan P. Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis. Nature Reviews Clinical Oncology. 2011;8(3):131–3.
Tan, I. B., and P. Tan. “Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis.” Nature Reviews Clinical Oncology, vol. 8, no. 3, 2011, pp. 131–33. Scival, doi:10.1038/nrclinonc.2010.229.
Tan IB, Tan P. Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis. Nature Reviews Clinical Oncology. 2011;8(3):131–133.

Published In

Nature Reviews Clinical Oncology

DOI

ISSN

1759-4774

Publication Date

2011

Volume

8

Issue

3

Start / End Page

131 / 133

Related Subject Headings

  • 1112 Oncology and Carcinogenesis